14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
PBUS vs USPX: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Invesco MSCI USA ETF (PBUS) is the stronger overall head-to-head candidate over Franklin U.S. Equity Index ETF (USPX) in the Tradestie Institutional Equity Comparison Engine, winning 1–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). PBUS carries a Unified Composite Score of 35.7/100 (SELL) at $69.08 (N/M Forward P/E, N/A operating margin), whereas USPX carries 39.9/100 (SELL) at $60.22 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While USPX currently prints a higher short-term Unified Composite Score (39.9/100 SELL vs. PBUS 35.7/100 SELL), PBUS captures the overall institutional head-to-head verdict (1–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
Defensive Composite Rating Caution: Although PBUS compares more favorably head-to-head, both PBUS (35.7/100 SELL) and USPX (39.9/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: PBUS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.9); meanwhile USPX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PBUS vs USPX. Trailing 12-month operating profitability (PBUS N/A vs USPX N/A) and valuation multiples (PBUS N/M vs USPX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ PBUS vs USPX Key Questions & Quantitative Answers
As of Nov 20, 2026, Invesco MSCI USA ETF (PBUS) is the stronger overall head-to-head candidate over Franklin U.S. Equity Index ETF (USPX) in the Tradestie Institutional Equity Comparison Engine, winning 1–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). PBUS carries a Unified Composite Score of 35.7/100 (SELL) at $69.08 (N/M Forward P/E, N/A operating margin), whereas USPX carries 39.9/100 (SELL) at $60.22 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While USPX currently prints a higher short-term Unified Composite Score (39.9/100 SELL vs. PBUS 35.7/100 SELL), PBUS captures the overall institutional head-to-head verdict (1–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY). Defensive Composite Rating Caution: Although PBUS compares more favorably head-to-head, both PBUS (35.7/100 SELL) and USPX (39.9/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: PBUS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.9); meanwhile USPX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
PBUS and USPX split Growth & Scale metrics: PBUS posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with USPX at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, PBUS generates N/A in USD-normalized revenue versus N/A for USPX. In operating R&D and SG&A reinvestment, PBUS deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for USPX.
PBUS and USPX trade at balanced relative valuation multiples. PBUS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas USPX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PBUS (N/A ROE) versus USPX (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, PBUS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.01β · 24% Vol realized risk). By comparison, USPX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.00β · 24% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.